Immune Microenvironment of Breast Ductal Carcinoma In SituImmune Microenvironment of Breast Ductal Carcinoma In Situ
This study investigates the immunobiology of DCIS breast cancers. How does the antitumor immune response evolve as tumors progress from in situ to invasive and then metastatic lesions? Modern Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 13, 2016 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
Pathologists Often Disagree on Biopsy FindingsPathologists Often Disagree on Biopsy Findings
Pathologists largely agree when identifying invasive breast cancer on breast biopsy slides, but agreement is much lower when those slides suggest atypia or ductal carcinoma in situ, a new study has found. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 30, 2016 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
Janice Dickinson reveals she has been diagnosed with breast cancer
The supermodel tells Daily Mail Online how she has been diagnosed with early stage ductal carcinoma in situ. But Dickinson, 61, said she is determined to beat the disease and will soon have surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - March 29, 2016 Category: Consumer Health News Source Type: news
Breast Biopsy Study Points to Need for a New "Gold Standard" (FREE)
By Joe Elia
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Breast biopsy findings, the gold standard for diagnosis, can vary widely among pathologists, especially with atypia and ductal carcinoma in situ (DCIS), according … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 21, 2016 Category: Primary Care Source Type: news
10-year DCIS recurrence risk dwindles with age
BOSTON – Recurrence rates of cancer following breast-conserving surgery for ductal carcinoma in situ differ significantly with patient age, with younger women having a three-fold higher 10-year... (Source: Family Practice News)
Source: Family Practice News - March 21, 2016 Category: Primary Care Source Type: news
What Is Breast Cancer Stage Zero?
Is Stage Zero breast cancer really cancer or not? Find out what the staging means for ductal or lobular carcinoma in situ in diagnosis and treatment. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - March 9, 2016 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news
Women Often Overestimate Odds That Early Breast Cancer Will Return, Spread (U.S. News and World Report)
This article contains commentary fr... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 8, 2016 Category: Cancer & Oncology Source Type: news
Dana-Farber using new grant to study less-is-more approach to breast cancer
For years, oncologists have aggressively treated an early form of non-invasive breast cancer with surgery and radiation, carving out any part of the breast that was deemed to be a future risk.
But with a $13.3 million grant from the Patient-Centered Outcomes Research Institute, Dana-Farber Cancer Institute will study whether such aggressive treatments are necessary for ductal carcinoma in situ (DCIS), and if a wait-and-see approach leads to better outcomes for the patient.
Approximately 60,000… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 8, 2016 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news
DCIS Prognostic Score Associated With Radiotherapy Survival BenefitDCIS Prognostic Score Associated With Radiotherapy Survival Benefit
A simple prognostic score identifies women with ductal carcinoma in situ (DCIS) who will derive a survival benefit from radiotherapy after breast-conserving therapy, according to a longitudinal study. Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 5, 2016 Category: Radiology Tags: Hematology-Oncology News Source Type: news
What's the best treatment for very early signs of breast cancer? Duke U. researchers want to know
With help from a $13.4 million award, Duke medical researchers will try to learn more about how to treat women with very early signs of breast cancer – an issue of no small debate in the oncology world.
Specifically, the research will look at ductal carcinoma in situ, or DCIS, a collection of abnormal cells found in breast ducts, but that have not spread. Some 60,000 women are diagnosed annually with DCIS, however there is growing research that indicates these women would never develop breast… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 4, 2016 Category: Biotechnology Authors: Jason deBruyn Source Type: news
Study Aims to Resolve How To Manage Pre-Cancers of the Breast
This study will provide so many answers to questions that are critical to resolve,” Hwang said. “One of the key features is the assessment of patient-reported outcomes with each approach, as we believe how patients view their disease and their care must be central to any advances in cancer treatment.”
The funding award for the DCIS study has been approved pending completion of a business and programmatic review by PCORI staff and issuance of a formal award contract.
PHOTO: Shelley Hwang, M.D., Duke Cancer Institute and Duke Department of Surgery. CREDIT: Duke Health. (Source: DukeHealth.org: Duke Health Features)
Source: DukeHealth.org: Duke Health Features - February 4, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news
MD Anderson shares in $13.4 million award to study treatment for low-grade DCIS
(University of Texas M. D. Anderson Cancer Center) Researchers at the University of Texas MD Anderson Cancer will share in a funding award of $13.4 million with hopes of answering one of the biggest questions in the current management of breast cancer: do women with the earliest form of the disease, ductal carcinoma in situ (DCIS), need invasive surgery? (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 2, 2016 Category: Cancer & Oncology Source Type: news
Does radiation therapy improve survival for women with ductal carcinoma in situ?
(Brigham and Women's Hospital) Investigators from Brigham and Women's Hospital (BWH) and the Dana-Farber Cancer Institute have found that a set of easily measurable risk factors can predict the magnitude of survival benefit offered by radiation therapy following breast cancer surgery. Their results appear online in The Journal of Clinical Oncology on Feb. 1. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2016 Category: Cancer & Oncology Source Type: news
Does Radiation Therapy Improve Survival for Women with Ductal Carcinoma in Situ (DCIS)? Yes...and...No.
Set of risk factors predict which patients with ductal carcinoma in situ (DCIS) will see a survival benefit from radiation therapy after breast cancer surgery. (Source: BWH News)
Source: BWH News - February 1, 2016 Category: Hospital Management Source Type: news
Does Radiation Therapy Improve Survival for Women with Ductal Carcinoma in Situ (DCIS)? Yes...and...No. (Dana-Farber/Brigham and Women’s Cancer Center)
Approximately 60,000 patients in the United States will receive a diagnosis of ductal carcinoma in situ (DCIS) in 2016. DCIS is not an invasive form of cancer and the 10-year survival rate for women with DCIS is greater than 98 percent. However, incidence of DCIS has increased dramatically over the last three decades, and being able to determine which women are among the small percentage at higher risk of breast cancer recurrence and mortality could help clinicians and patients tailor treatment ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 1, 2016 Category: Cancer & Oncology Source Type: news
